title: Control of growth in the neonatal pig heart.
abstract: The newborn heart is an excellent model in which to study cardiac growth because the neonatal period is a normal situation in which the left ventricle (LV) grows rapidly and the right ventricle grows slowly. Accelerated LV growth is in response to mechanical, neural, and endocrine changes at birth. Faster growth of the LV is accounted for by greater capacity for protein synthesis, as evidenced by greater RNA content. At 18 h of life, ribosomes are formed in preference to total heart protein, but at 48 h of life, faster rates of both ribosome formation and total protein synthesis are observed. In the LV of hearts from 2-day-old pigs, these rates are insensitive to the addition of glucagon, 1-methyl-3-isobutylxanthine, or a combination of norepinephrine and propranolol. These observations could result because of maximal growth stimulation already present in the LV of the newborn heart. To restrain LV growth in the neonatal period, we treated pigs with enalapril maleate, an angiotensin II-converting enzyme inhibitor. Enalapril blocked growth of the LV as well as the increase in RNA content. When hearts from enalapril-treated pigs were perfused in vitro, rates of protein synthesis and ribosome formation in the LV were lower. These studies suggest that angiotensin II is an important factor accounting for rapid growth of the neonatal heart in response to pressure overload at birth.
authors.affiliation: Sigfried and Janet Weis Center for Research, Geisinger Clinic, Danville, Pennsylvania 17822.
authors.forename: C J
authors.initials: CJ
authors.lastname: Beinlich
authors.forename: K M
authors.initials: KM
authors.lastname: Baker
authors.forename: G J
authors.initials: GJ
authors.lastname: White
authors.forename: H E
authors.initials: HE
authors.lastname: Morgan
mesh_terms: D015056:1-Methyl-3-isobutylxanthine / Q000494:pharmacology; D000818:Animals; D000831:Animals, Newborn / Q000254:growth & development*; D000242:Cyclic AMP / Q000378:metabolism; D004656:Enalapril / Q000494:pharmacology; D005934:Glucagon / Q000494:pharmacology; D006321:Heart / Q000187:drug effects / Q000254:growth & development*; D006339:Heart Rate / Q000187:drug effects; D066298:In Vitro Techniques; D009124:Muscle Proteins / Q000096:biosynthesis; D009206:Myocardium / Q000166:cytology / Q000378:metabolism; D009638:Norepinephrine / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D011494:Protein Kinases / Q000378:metabolism; D012270:Ribosomes / Q000502:physiology; D013552:Swine
chemical_list: D009124:Muscle Proteins; D004656:Enalapril; D005934:Glucagon; D011433:Propranolol; D000242:Cyclic AMP; D011494:Protein Kinases; D015056:1-Methyl-3-isobutylxanthine; D009638:Norepinephrine